IntegraGen SA ALINT.PA Stock
IntegraGen SA Price Chart
IntegraGen SA ALINT.PA Financial and Trading Overview
IntegraGen SA stock price | 0.69 EUR |
Previous Close | 1.3 EUR |
Open | 1.3 EUR |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 1.3 - 1.3 EUR |
52 Week Range | 1.04 - 1.53 EUR |
Volume | 142 EUR |
Avg. Volume | 1.7K EUR |
Market Cap | 8.65M EUR |
Beta (5Y Monthly) | 0.290421 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.02 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ALINT.PA Valuation Measures
Enterprise Value | 5.78M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.6549025 |
Price/Book (mrq) | 3.9513676 |
Enterprise Value/Revenue | 0.438 |
Enterprise Value/EBITDA | 92.597 |
Trading Information
IntegraGen SA Stock Price History
Beta (5Y Monthly) | 0.290421 |
52-Week Change | 19.26% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.53 EUR |
52 Week Low | 1.04 EUR |
50-Day Moving Average | 1.29 EUR |
200-Day Moving Average | 1.26 EUR |
ALINT.PA Share Statistics
Avg. Volume (3 month) | 1.7K EUR |
Avg. Daily Volume (10-Days) | 1.75K EUR |
Shares Outstanding | 6.63M |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 65.89% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -0.025% |
Operating Margin (ttm) | -1.052% |
Gross Margin | 40.74% |
EBITDA Margin | 0.47% |
Management Effectiveness
Return on Assets (ttm) | -0.93% |
Return on Equity (ttm) | -0.16% |
Income Statement
Revenue (ttm) | 13.21M EUR |
Revenue Per Share (ttm) | 1.99 EUR |
Quarterly Revenue Growth (yoy) | 2.00% |
Gross Profit (ttm) | N/A |
EBITDA | 62.44K EUR |
Net Income Avi to Common (ttm) | -3503 EUR |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | -67.60% |
Balance Sheet
Total Cash (mrq) | 4.51M EUR |
Total Cash Per Share (mrq) | 0.68 EUR |
Total Debt (mrq) | 1.67M EUR |
Total Debt/Equity (mrq) | 76.61 EUR |
Current Ratio (mrq) | 1.501 |
Book Value Per Share (mrq) | 0.329 |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of IntegraGen SA
Country | France |
State | N/A |
City | Évry |
Address | Genopole Campus 1 BAt. 8 |
ZIP | 91000 |
Phone | 33 1 60 91 09 00 |
Website | https://integragen.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 63 |
IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics; basic and human genetic research; agrigenomic services, including crop and livestock genotyping and high-throughput sequencing for crops and livestock; and microbial genomics services comprising whole-genome microbial sequencing and microbial transcriptomics. It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; SIRIUS, a cloud-based software tool that enables researchers to analyze whole genome, whole exome, and gene panel sequencing data; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts. IntegraGen SA was founded in 2000 and is headquartered in Évry, France. IntegraGen SA is a subsidiary of OncoDNA SA.
Q&A For IntegraGen SA Stock
What is a current ALINT.PA stock price?
IntegraGen SA ALINT.PA stock price today per share is 0.69 EUR.
How to purchase IntegraGen SA stock?
You can buy ALINT.PA shares on the Paris exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IntegraGen SA?
The stock symbol or ticker of IntegraGen SA is ALINT.PA.
Which industry does the IntegraGen SA company belong to?
The IntegraGen SA industry is Biotechnology.
How many shares does IntegraGen SA have in circulation?
The max supply of IntegraGen SA shares is 6.64M.
What is IntegraGen SA Price to Earnings Ratio (PE Ratio)?
IntegraGen SA PE Ratio is now.
What was IntegraGen SA earnings per share over the trailing 12 months (TTM)?
IntegraGen SA EPS is -0.02 EUR over the trailing 12 months.
Which sector does the IntegraGen SA company belong to?
The IntegraGen SA sector is Healthcare.